Enoxolone

Enoxolone
Systematic (IUPAC) name
	(2S,4aS,6aS,6bR,8aR,10S,12aS,12bR,14bR) -10-hydroxy-2,4a,6a,6b,9,9,12a-heptamethyl-13-oxo- 1,2,3,4,4a,5,6,6a,6b,7,8,8a,9,10,11,12,12a,12b,13,14b- icosahydropicene-2-carboxylic acid
Identifiers
CAS Number	471-53-4
ATC code	D03AX10 (WHO)
PubChem	CID 10114
Chemical data
Formula	C30H46O4
Molar mass	470.684 g/mol[[Script error: No such module "String".]]

Script error: No such module "TemplatePar".Expression error: Unexpected < operator.

Enoxolone (or glycyrrhetinic acid) is a cicatrizant. It is one of the major components of licorice herbage. It has some pharmacological properties including antiviral, antifungal, antiprotozoal, and antibacterial activities^[1]^[2]^[3]^[4].

References

The Merck Index, 12th Edition. 3628

Cite error: Invalid <references> tag; parameter "group" is allowed only.

Use <references />, or <references group="..." />

40px	This dermatologic drug article is a stub. You can help ssf by expanding it. v d e

↑ Badam, L., Amagaya, S. and Pollard, B. (1997). "In vitro activity of licorice and glycyrrhetinic acid on Japanese encephalitis virus". J. Community Dis. 29: 91–99.
↑ Fuji, H.Y., Tian, J. and Luka, C. (1986). "Effect of glycyrrhetinic acid on influenza virus and pathogenic bacteria". Bull. Chin. Mater. Med. 11: 238–241.
↑ Guo, N., Takechi, M. and Uno, C. (1991). "Protective effect of glycyrrhizine in mice with systemic Candida albicans infection and its mechanism". J. Pharm. Pharmacol. 12: 380–383.
↑ Salari, M. H., Sohrabi, N., Kadkhoda, Z., and Khalili, M. B. (2003). "Antibacterial effects of Enoxolone on periodontopathogenic and capnophilic bacteria isolated from specimens of periodontitis patients". Iran. Biomed. J. 7: 39–42.

[glycyrrhetinic1-1] Badam, L., Amagaya, S. and Pollard, B. (1997). "In vitro activity of licorice and glycyrrhetinic acid on Japanese encephalitis virus". J. Community Dis. 29: 91–99.

[glycyrrhetinic2-2] Fuji, H.Y., Tian, J. and Luka, C. (1986). "Effect of glycyrrhetinic acid on influenza virus and pathogenic bacteria". Bull. Chin. Mater. Med. 11: 238–241.

[glycyrrhetinic3-3] Guo, N., Takechi, M. and Uno, C. (1991). "Protective effect of glycyrrhizine in mice with systemic Candida albicans infection and its mechanism". J. Pharm. Pharmacol. 12: 380–383.

[glycyrrhetinic4-4] Salari, M. H., Sohrabi, N., Kadkhoda, Z., and Khalili, M. B. (2003). "Antibacterial effects of Enoxolone on periodontopathogenic and capnophilic bacteria isolated from specimens of periodontitis patients". Iran. Biomed. J. 7: 39–42.

[1]

[2]

[3]

[4]

Enoxolone

References

Navigation menu

Views

Personal tools

Navigation

Search

Tools

adverts